MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...

Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...

Many users face issues when installing Windows 11, such as the installation getting stuck due to system requirements like TPM 2.0, Secure Boot, or unsupported ...

Models engage in actual debate (see and respond to each other) Multi-round convergence with voting and confidence levels Full audit trail with AI-generated summaries Automatic early stopping when ...

Bug description @prisma/adapter-better-sqlite3 currently depends on better-sqlite3 ^11.0.0. better-sqlite3 attempts to download a prebuilt binary during installation, and falls back to building via ...